Brad S Shumel

Title: Brad S. Shumel: Innovator in Dermatological Treatments

Introduction

Brad S. Shumel is a notable inventor based in Chappaqua, NY (US). He has made significant contributions to the field of dermatology, particularly in the treatment of severe atopic dermatitis. With a total of 3 patents to his name, Shumel's work has the potential to impact many lives suffering from this condition.

Latest Patents

One of his latest patents focuses on methods for treating severe atopic dermatitis by administering an IL-4R inhibitor. This invention provides methods for treating moderate-to-severe or severe atopic dermatitis (AD). The methods involve administering to a subject in need one or more doses of an interleukin-4 receptor (IL-4R) inhibitor, such as an anti-IL-4R antibody. In certain embodiments, these methods are particularly useful for treating severe AD in patients whose disease is not controlled with systemic therapy, such as cyclosporine A, or when such therapy is inadvisable.

Career Highlights

Throughout his career, Brad S. Shumel has worked with prominent companies in the biotechnology sector. He has been associated with Regeneron Pharmaceuticals, Inc. and Sanofi Biotechnology, where he has contributed to innovative research and development efforts.

Collaborations

Shumel has collaborated with notable professionals in his field, including Allen Radin and Neil John Graham. These collaborations have likely enriched his research and contributed to the success of his inventions.

Conclusion

Brad S. Shumel is a distinguished inventor whose work in treating severe atopic dermatitis showcases his commitment to advancing medical science. His innovative approaches and collaborations highlight the importance of teamwork in achieving breakthroughs in healthcare.